- IBDEI0TF ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,13239,2)
- ;;=^5005907
- ;;^UTILITY(U,$J,358.3,13240,0)
- ;;=H40.61X2^^51^632^49
- ;;^UTILITY(U,$J,358.3,13240,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13240,1,3,0)
- ;;=3^GLU 2nd to Drugs,OD,Moderate Stage
- ;;^UTILITY(U,$J,358.3,13240,1,4,0)
- ;;=4^H40.61X2
- ;;^UTILITY(U,$J,358.3,13240,2)
- ;;=^5005908
- ;;^UTILITY(U,$J,358.3,13241,0)
- ;;=H40.61X3^^51^632^50
- ;;^UTILITY(U,$J,358.3,13241,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13241,1,3,0)
- ;;=3^GLU 2nd to Drugs,OD,Severe Stage
- ;;^UTILITY(U,$J,358.3,13241,1,4,0)
- ;;=4^H40.61X3
- ;;^UTILITY(U,$J,358.3,13241,2)
- ;;=^5133509
- ;;^UTILITY(U,$J,358.3,13242,0)
- ;;=H40.61X4^^51^632^51
- ;;^UTILITY(U,$J,358.3,13242,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13242,1,3,0)
- ;;=3^GLU 2nd to Drugs,OD,Indeterminate Stage
- ;;^UTILITY(U,$J,358.3,13242,1,4,0)
- ;;=4^H40.61X4
- ;;^UTILITY(U,$J,358.3,13242,2)
- ;;=^5005909
- ;;^UTILITY(U,$J,358.3,13243,0)
- ;;=H40.813^^51^632^64
- ;;^UTILITY(U,$J,358.3,13243,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13243,1,3,0)
- ;;=3^GLC w/ Increased Episcleral Venous Pressure,OU
- ;;^UTILITY(U,$J,358.3,13243,1,4,0)
- ;;=4^H40.813
- ;;^UTILITY(U,$J,358.3,13243,2)
- ;;=^5005921
- ;;^UTILITY(U,$J,358.3,13244,0)
- ;;=H40.811^^51^632^62
- ;;^UTILITY(U,$J,358.3,13244,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13244,1,3,0)
- ;;=3^GLC w/ Increased Episcleral Venous Pressure,OD
- ;;^UTILITY(U,$J,358.3,13244,1,4,0)
- ;;=4^H40.811
- ;;^UTILITY(U,$J,358.3,13244,2)
- ;;=^5005919
- ;;^UTILITY(U,$J,358.3,13245,0)
- ;;=H40.812^^51^632^63
- ;;^UTILITY(U,$J,358.3,13245,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13245,1,3,0)
- ;;=3^GLC w/ Increased Episcleral Venous Pressure,OS
- ;;^UTILITY(U,$J,358.3,13245,1,4,0)
- ;;=4^H40.812
- ;;^UTILITY(U,$J,358.3,13245,2)
- ;;=^5005920
- ;;^UTILITY(U,$J,358.3,13246,0)
- ;;=H40.823^^51^632^67
- ;;^UTILITY(U,$J,358.3,13246,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13246,1,3,0)
- ;;=3^Hypersecretion GLC,OU
- ;;^UTILITY(U,$J,358.3,13246,1,4,0)
- ;;=4^H40.823
- ;;^UTILITY(U,$J,358.3,13246,2)
- ;;=^5005925
- ;;^UTILITY(U,$J,358.3,13247,0)
- ;;=H40.821^^51^632^65
- ;;^UTILITY(U,$J,358.3,13247,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13247,1,3,0)
- ;;=3^Hypersecretion GLC,OD
- ;;^UTILITY(U,$J,358.3,13247,1,4,0)
- ;;=4^H40.821
- ;;^UTILITY(U,$J,358.3,13247,2)
- ;;=^5005923
- ;;^UTILITY(U,$J,358.3,13248,0)
- ;;=H40.822^^51^632^66
- ;;^UTILITY(U,$J,358.3,13248,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13248,1,3,0)
- ;;=3^Hypersecretion GLC,OS
- ;;^UTILITY(U,$J,358.3,13248,1,4,0)
- ;;=4^H40.822
- ;;^UTILITY(U,$J,358.3,13248,2)
- ;;=^5005924
- ;;^UTILITY(U,$J,358.3,13249,0)
- ;;=H40.43X0^^51^632^27
- ;;^UTILITY(U,$J,358.3,13249,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13249,1,3,0)
- ;;=3^Inflam GLC,OU,Stage Unspec
- ;;^UTILITY(U,$J,358.3,13249,1,4,0)
- ;;=4^H40.43X0
- ;;^UTILITY(U,$J,358.3,13249,2)
- ;;=^5005878
- ;;^UTILITY(U,$J,358.3,13250,0)
- ;;=H40.43X1^^51^632^28
- ;;^UTILITY(U,$J,358.3,13250,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13250,1,3,0)
- ;;=3^Inflam GLC,OU,Mild Stage
- ;;^UTILITY(U,$J,358.3,13250,1,4,0)
- ;;=4^H40.43X1
- ;;^UTILITY(U,$J,358.3,13250,2)
- ;;=^5005879
- ;;^UTILITY(U,$J,358.3,13251,0)
- ;;=H40.43X2^^51^632^29
- ;;^UTILITY(U,$J,358.3,13251,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,13251,1,3,0)
- ;;=3^Inflam GLC,OU,Moderate Stage
- ;;^UTILITY(U,$J,358.3,13251,1,4,0)
- ;;=4^H40.43X2
- ;;^UTILITY(U,$J,358.3,13251,2)
- ;;=^5005880
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0TF 3759 printed Jan 18, 2025@02:56:38 Page 2
- IBDEI0TF ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,13239,2)
- +2 ;;=^5005907
- +3 ;;^UTILITY(U,$J,358.3,13240,0)
- +4 ;;=H40.61X2^^51^632^49
- +5 ;;^UTILITY(U,$J,358.3,13240,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,13240,1,3,0)
- +8 ;;=3^GLU 2nd to Drugs,OD,Moderate Stage
- +9 ;;^UTILITY(U,$J,358.3,13240,1,4,0)
- +10 ;;=4^H40.61X2
- +11 ;;^UTILITY(U,$J,358.3,13240,2)
- +12 ;;=^5005908
- +13 ;;^UTILITY(U,$J,358.3,13241,0)
- +14 ;;=H40.61X3^^51^632^50
- +15 ;;^UTILITY(U,$J,358.3,13241,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,13241,1,3,0)
- +18 ;;=3^GLU 2nd to Drugs,OD,Severe Stage
- +19 ;;^UTILITY(U,$J,358.3,13241,1,4,0)
- +20 ;;=4^H40.61X3
- +21 ;;^UTILITY(U,$J,358.3,13241,2)
- +22 ;;=^5133509
- +23 ;;^UTILITY(U,$J,358.3,13242,0)
- +24 ;;=H40.61X4^^51^632^51
- +25 ;;^UTILITY(U,$J,358.3,13242,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,13242,1,3,0)
- +28 ;;=3^GLU 2nd to Drugs,OD,Indeterminate Stage
- +29 ;;^UTILITY(U,$J,358.3,13242,1,4,0)
- +30 ;;=4^H40.61X4
- +31 ;;^UTILITY(U,$J,358.3,13242,2)
- +32 ;;=^5005909
- +33 ;;^UTILITY(U,$J,358.3,13243,0)
- +34 ;;=H40.813^^51^632^64
- +35 ;;^UTILITY(U,$J,358.3,13243,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,13243,1,3,0)
- +38 ;;=3^GLC w/ Increased Episcleral Venous Pressure,OU
- +39 ;;^UTILITY(U,$J,358.3,13243,1,4,0)
- +40 ;;=4^H40.813
- +41 ;;^UTILITY(U,$J,358.3,13243,2)
- +42 ;;=^5005921
- +43 ;;^UTILITY(U,$J,358.3,13244,0)
- +44 ;;=H40.811^^51^632^62
- +45 ;;^UTILITY(U,$J,358.3,13244,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,13244,1,3,0)
- +48 ;;=3^GLC w/ Increased Episcleral Venous Pressure,OD
- +49 ;;^UTILITY(U,$J,358.3,13244,1,4,0)
- +50 ;;=4^H40.811
- +51 ;;^UTILITY(U,$J,358.3,13244,2)
- +52 ;;=^5005919
- +53 ;;^UTILITY(U,$J,358.3,13245,0)
- +54 ;;=H40.812^^51^632^63
- +55 ;;^UTILITY(U,$J,358.3,13245,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,13245,1,3,0)
- +58 ;;=3^GLC w/ Increased Episcleral Venous Pressure,OS
- +59 ;;^UTILITY(U,$J,358.3,13245,1,4,0)
- +60 ;;=4^H40.812
- +61 ;;^UTILITY(U,$J,358.3,13245,2)
- +62 ;;=^5005920
- +63 ;;^UTILITY(U,$J,358.3,13246,0)
- +64 ;;=H40.823^^51^632^67
- +65 ;;^UTILITY(U,$J,358.3,13246,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,13246,1,3,0)
- +68 ;;=3^Hypersecretion GLC,OU
- +69 ;;^UTILITY(U,$J,358.3,13246,1,4,0)
- +70 ;;=4^H40.823
- +71 ;;^UTILITY(U,$J,358.3,13246,2)
- +72 ;;=^5005925
- +73 ;;^UTILITY(U,$J,358.3,13247,0)
- +74 ;;=H40.821^^51^632^65
- +75 ;;^UTILITY(U,$J,358.3,13247,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,13247,1,3,0)
- +78 ;;=3^Hypersecretion GLC,OD
- +79 ;;^UTILITY(U,$J,358.3,13247,1,4,0)
- +80 ;;=4^H40.821
- +81 ;;^UTILITY(U,$J,358.3,13247,2)
- +82 ;;=^5005923
- +83 ;;^UTILITY(U,$J,358.3,13248,0)
- +84 ;;=H40.822^^51^632^66
- +85 ;;^UTILITY(U,$J,358.3,13248,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,13248,1,3,0)
- +88 ;;=3^Hypersecretion GLC,OS
- +89 ;;^UTILITY(U,$J,358.3,13248,1,4,0)
- +90 ;;=4^H40.822
- +91 ;;^UTILITY(U,$J,358.3,13248,2)
- +92 ;;=^5005924
- +93 ;;^UTILITY(U,$J,358.3,13249,0)
- +94 ;;=H40.43X0^^51^632^27
- +95 ;;^UTILITY(U,$J,358.3,13249,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,13249,1,3,0)
- +98 ;;=3^Inflam GLC,OU,Stage Unspec
- +99 ;;^UTILITY(U,$J,358.3,13249,1,4,0)
- +100 ;;=4^H40.43X0
- +101 ;;^UTILITY(U,$J,358.3,13249,2)
- +102 ;;=^5005878
- +103 ;;^UTILITY(U,$J,358.3,13250,0)
- +104 ;;=H40.43X1^^51^632^28
- +105 ;;^UTILITY(U,$J,358.3,13250,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,13250,1,3,0)
- +108 ;;=3^Inflam GLC,OU,Mild Stage
- +109 ;;^UTILITY(U,$J,358.3,13250,1,4,0)
- +110 ;;=4^H40.43X1
- +111 ;;^UTILITY(U,$J,358.3,13250,2)
- +112 ;;=^5005879
- +113 ;;^UTILITY(U,$J,358.3,13251,0)
- +114 ;;=H40.43X2^^51^632^29
- +115 ;;^UTILITY(U,$J,358.3,13251,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,13251,1,3,0)
- +118 ;;=3^Inflam GLC,OU,Moderate Stage
- +119 ;;^UTILITY(U,$J,358.3,13251,1,4,0)
- +120 ;;=4^H40.43X2
- +121 ;;^UTILITY(U,$J,358.3,13251,2)
- +122 ;;=^5005880